Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XELODA for Rectal cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 48 adverse event reports in the FDA FAERS database where XELODA was used for Rectal cancer.

Most Reported Side Effects for XELODA

Side Effect Reports % Deaths Hosp.
Death 303 28.2% 302 13
Diarrhoea 141 13.1% 31 53
Disease progression 137 12.7% 42 13
Nausea 81 7.5% 19 30
Vomiting 71 6.6% 13 41
Palmar-plantar erythrodysaesthesia syndrome 70 6.5% 5 16
Fatigue 50 4.7% 10 12
Malignant neoplasm progression 45 4.2% 8 7
Pain 37 3.4% 9 13
Asthenia 36 3.4% 9 20
Decreased appetite 32 3.0% 8 17
Dehydration 32 3.0% 10 22
Weight decreased 31 2.9% 3 14
Abdominal pain 29 2.7% 7 18
Breast cancer 29 2.7% 3 2

Other Indications for XELODA

Product used for unknown indication (215) Colon cancer (157) Breast cancer (147) Breast cancer metastatic (102) Colorectal cancer (68) Gastric cancer (56) Pancreatic carcinoma (25) Colorectal cancer metastatic (23) Colon cancer metastatic (22) Oesophageal carcinoma (18)

Other Drugs Used for Rectal cancer

CAPECITABINE (2,976) OXALIPLATIN (2,402) FLUOROURACIL (1,610) BEVACIZUMAB (1,546) TIPIRACIL\TRIFLURIDINE (1,297) IRINOTECAN (985) LEUCOVORIN (660) CETUXIMAB (542) REGORAFENIB (505) PANITUMUMAB (374)

Related Pages

XELODA Full Profile All Rectal cancer Drugs XELODA Demographics XELODA Timeline